ГОРДОН, Макс (US),ТАРДИ, Пол (CA),ТАЙНЕР, Джеффри (US),МАЙЕР, Лоренс (CA)
申请号：
RU2018121249
公开号：
RU2018121249A
申请日:
2016.11.10
申请国别(地区):
RU
年份:
2019
代理人:
摘要：
Diagnostic methods for identifying cancer bearing subjects appropriate for treatment with CPX-351 include genetic and ex vivo testing of cells from a candidate subject. Combination treatment with CPX-351 and FLT-3 inhibitors improve CPX-351 uptake and toxicity.
